![Grete Hogstad](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Grete Hogstad
Corporate Officer/Principal presso Association for Accessible Medicines
Patrimonio netto: 191 892 $ in data 31/05/2024
Profilo
Grete Hogstad is currently a Member at the Association for Accessible Medicines.
Previously, she held positions as a Director at Navamedic ASA, Alpharma, Inc., and Xellia Pharmaceuticals AS.
From 2005 to 2023, she served as the VP-Strategic Marketing & Business Development at Photocure ASA. Ms. Hogstad has an undergraduate degree from the University of Oslo and BI Norwegian Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PHOTOCURE ASA
0.11% | 31/12/2022 | 30 719 ( 0.11% ) | 191 892 $ | 31/05/2024 |
Posizioni attive di Grete Hogstad
Società | Posizione | Inizio |
---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Corporate Officer/Principal | - |
Precedenti posizioni note di Grete Hogstad
Società | Posizione | Fine |
---|---|---|
PHOTOCURE ASA | Vendite & Marketing | 01/07/2023 |
Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Vendite & Marketing | - |
Xellia Pharmaceuticals AS
![]() Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Vendite & Marketing | - |
NAVAMEDIC ASA | Direttore/Membro del Consiglio | - |
Formazione di Grete Hogstad
University of Oslo | Undergraduate Degree |
BI Norwegian Business School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PHOTOCURE ASA | Health Technology |
NAVAMEDIC ASA | Distribution Services |
Aziende private | 3 |
---|---|
Xellia Pharmaceuticals AS
![]() Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Health Technology |
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Health Technology |
- Borsa valori
- Insiders
- Grete Hogstad